Adaptimmune Therapeutics plc ( ADAPY) - Key Metrics
ADAPY Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $0.05 | -$0.11 | -$0.13 | -$0.13 |
| 2025Q1 | $0.03 | -$0.19 | -$0.26 | -$0.26 |
| 2024Q4 | $0.01 | -$0.29 | -$0.13 | -$0.14 |
| 2024Q3 | $0.16 | -$0.07 | -$0.21 | -$0.21 |
| 2024Q2 | $0.50 | $0.27 | $0.19 | $0.18 |
ADAPY Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | 0% | -0.51 |
| 2025Q1 | 0% | -0.26 |
| 2024Q4 | 0% | -0.47 |
| 2024Q3 | 0% | -3.44 |
| 2024Q2 | 0% | 0.97 |
ADAPY
Price: $0.03
52 week price:
Earnings Per Share: -0.66 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.2 million